Yael Kislev

Showing 1-2 of 2 articles

Interventions for valvular disease

Non-implant valve repair for calcific aortic stenosis: The Leaflex Study

Baumbach A, Mylotte D, Hildick-Smith D, Kennon S, Jonas M, Bartuś K, Trebacz J, Halevi R, Kislev Y, Plotnikov L, Andreka P

September 15, 2020 | 10.4244/EIJ-D-20-00458

The Leaflex™ Catheter System – a viable treatment option alongside valve replacement? Preclinical feasibility of a novel device designed for fracturing aortic valve calcification

Jonas M, Rozenman Y, Moshkovitz Y, Hamdan A, Kislev Y, Tirosh N, Sax S, Trumer D, Golan E, Raanani E

September 22, 2015 | 10.4244/EIJY14M11_10

1

Latest news

Ischaemia with non-obstructive coronary arteries, OCT vs IVUS guidance in PCI; the ILUMIEN III and ILUMIEN IV trials…

January 20, 2021

The Year in Review

M. Lunardi et al

January 22, 2021

Elective Cardiac Invasive Procedures during the COVID-19 Outbreak

A. Chieffo et al.

January 8, 2021

Smoke signals – do they help to predict TAVI-associated stroke risk?

R. Kharbanda et al.

January 25, 2021

SCOPE 2, BASKET-SMALL 2 3 years, ALPHEUS, COMPARE-ABSORB, DUBIUS

(Thanks to the support of Biotronik)

January 13, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

This Week's JAA's: Redo-TAVI, Major bleeding in the Amulet Observational Study, OCT findings in ESR...

January 26, 2021

Valvular disease